Automated description from the Alliance of Genome Resources (Release 3.1.1)
Predicted to have serine-type endopeptidase inhibitor activity. Predicted to be involved in acute-phase response; hyaluronan metabolic process; and negative regulation of peptidase activity. Localizes to cytoplasm and plasma membrane. Is expressed in brain; heart; liver; and lung. Human ortholog(s) of this gene implicated in intermediate coronary syndrome and myocardial infarction. Orthologous to human ITIH4 (inter-alpha-trypsin inhibitor heavy chain 4).